Steven Artz, MD
Endocrinology, Diabetes & Metabolism · Charleston, WVNPI 1164529475
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $530 and has fallen 90.1% since, to $52 in 2024. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in WV, where the typical reported total is $1,166.
Across 61 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$273
- Abbott$160
- Sanofi-aventis U.S. LLC$138
- Johnson & Johnson$123
- Novo Nordisk$77
- Bayer$63
- plus $440 from 15 others
What the payments were for
- Food & beverage$1,274100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 14 | $273 |
| Abbott | 14 | $160 |
| Sanofi-aventis U.S. LLC | 3 | $138 |
| Johnson & Johnson | 1 | $123 |
| Novo Nordisk | 5 | $77 |
| Bayer | 1 | $63 |
| Tandem Diabetes Care, Inc. | 1 | $61 |
| Dexcom, Inc. | 1 | $52 |
| Merck | 3 | $48 |
| Amarin Pharma, Inc. | 3 | $48 |
| AstraZeneca | 3 | $40 |
| AbbVie | 2 | $37 |
| Boehringer Ingelheim | 2 | $33 |
| Janssen Scientific Affairs, LLC | 1 | $24 |
| Insulet Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $14 |
| Phadia US Inc. | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Nevro Corp. | 1 | $11 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
| Philips North America LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVOKANA$123
How this compares
$1,274 in reported general payments places this provider in the 50th percentile of 57 endocrinology, diabetes & metabolism providers in West Virginia.
See all endocrinology, diabetes & metabolism providers in West Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 31 | $29,147 |
| JardianceEmpagliflozin | 22 | $22,192 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $5,327 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $3,458 |
| Novolog FlexpenInsulin Aspart | 12 | $1,542 |
| SynthroidLevothyroxine Sodium | 11 | $1,092 |
| Levothyroxine Sodium | 33 | $420 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $14 | $29,14731 claims |
| Boehringer IngelheimJardiance | $33 | $22,19222 claims |
| AbbVieSynthroid | $37 | $1,09211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 57 endocrinology, diabetes & metabolism providers in West Virginia.
Other endocrinology, diabetes & metabolism in Charleston
- Samar SankariCharleston$8K
- Brian AprillCharleston$6K
- Lee Ann SkaffCharleston$2K
- Nicholas CassisCharleston$2K
- Ilia BernsteinCharleston$2K
- Raghda SahloulCharleston$558
- Glenn CrottyCharleston$422
- Stephen GrubbCharleston$198
- Daniel MaciasHuntington$686K
- Zachary KistkaMartinsburg$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.